Raymond James Financial Services Advisors, Inc. Bridge Bio Pharma, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$46.47 - $63.93 $502,619 - $691,466	-10,816 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$55.47 - $72.35 $6,878 - $8,971	-124 Reduced 1.13%	10,816 $666,000
Q4 2020 Feb 12, 2021	BUY	$38.38 - $71.11 $137,246 - $254,289	3,576 Added 48.56%	10,940 $778,000
Q3 2020 Nov 04, 2020	BUY	$27.2 - $42.19 $200,300 - $310,687	7,364 New	7,364 $276,000

Others Institutions Holding BBIO

# of Institutions

291

Shares Held

171M

Call Options Held

10.4M

Put Options Held

2.37M

Kohlberg Kravis Roberts & Co. L.P. New York, NY

25.3M
Shares

$592 Million
35.94% of portfolio
Viking Global Investors LP

25.1M
Shares

$588 Million
2.47% of portfolio
Vanguard Group Inc Valley Forge, PA

14.2M
Shares

$333 Million
0.01% of portfolio
Black Rock Inc. New York, NY

12.4M
Shares

$292 Million
0.01% of portfolio
Aisling Capital Management LP New York, NY

6.07M
Shares

$142 Million
63.58% of portfolio

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.47B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account